




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、中國(guó)科技論文在線- PAGE 6 - FORMTEXT Smac蛋白與腫瘤輻射敏感性基金項(xiàng)目:國(guó)家自然科學(xué)基金(30800281,31170804);天津市自然科學(xué)基金重點(diǎn)項(xiàng)目(10JCZDJC16900,11ZCGYSY02400);教育部高等學(xué)校博士學(xué)科點(diǎn)專項(xiàng)科研基金(200800231051,20101106110046)。 FORMTEXT 劉強(qiáng)1,2, FORMTEXT 杜利清1, FORMTEXT 曹嘉1, FORMTEXT 王彥1, FORMTEXT 王宏1, FORMTEXT 陳鳳華1, FORMTEXT 付岳1, FORMTEXT 郭艷婷1, FORMTEXT 樊飛躍1作者簡(jiǎn)
2、介:劉強(qiáng)(1974-),男,研究員,主要從事放射生物學(xué)研究通信聯(lián)系人:樊飛躍(1958-),男,研究員,主要從事放射生物學(xué)研究. E-mail: faithyfanSET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFOR
3、MAT1.5SET bkCompanyEN Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy
4、 of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Ins
5、titute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Pek
6、ing Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192 * MERGEFORMATInstitute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Ra
7、diation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Me
8、dical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese
9、 Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 30
10、0192SET bkCompanyCHN 中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;天津市分子核醫(yī)學(xué)重點(diǎn)實(shí)驗(yàn)室,天津 300192;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所 * MERGEFORMAT中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;天津市分子核醫(yī)學(xué)重點(diǎn)實(shí)驗(yàn)室,天津 300192;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放
11、射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所SET bkPostcode 300192;300192 * MERGEFORMAT300192;300192SET bkMobile13672122168 * MERGEFORMA13672122168SET bkTelphone022-85683036 * MERGEFORMA022-85683036SET bkAddress 天津市南開(kāi)區(qū)白堤路238號(hào);天津市南開(kāi)區(qū)白堤路238號(hào)
12、* MERGEFORMAT天津市南開(kāi)區(qū)白堤路238號(hào);天津市南開(kāi)區(qū)白堤路238號(hào)SET bkEmail dr.qiangliu;jillpumc;bamboo19750930;biotechong;wddr0710;faithyfan * MERGEFORMATdr.qiangliu;jillpumc;bamboo19750930;biotechong;wddr0710;faithyfanSET bkIntroduction 劉強(qiáng)(1974-),男,研究員,主要從事放射生物學(xué)研究;樊飛躍(1958-),男,研究員,主要從事放射生物學(xué)研究 * MERGEFORMAT劉強(qiáng)(1974-),男,研究員
13、,主要從事放射生物學(xué)研究;樊飛躍(1958-),男,研究員,主要從事放射生物學(xué)研究SET bkAuthorCHN 劉強(qiáng);杜利清;曹嘉;王彥;王宏;陳鳳華;付岳;郭艷婷;樊飛躍 * MERGEFORMAT劉強(qiáng);杜利清;曹嘉;王彥;王宏;陳鳳華;付岳;郭艷婷;樊飛躍SET bkAuthorEN Liu Qiang;Du Liqing;Cao Jia;Wang Yan;Wang Hong;Chen Fenghua;Fu Yue;Guo Yanting;Fan Feiyue * MERGEFORMATLiu Qiang;Du Liqing;Cao Jia;Wang Yan;Wang Hong;Chen
14、 Fenghua;Fu Yue;Guo Yanting;Fan FeiyueSET bkContact 樊飛躍 * MERGEFORMAT樊飛躍SET bkFund 國(guó)家自然科學(xué)基金(30800281,31170804);天津市自然科學(xué)基金重點(diǎn)項(xiàng)目(10JCZDJC16900,11ZCGYSY02400);教育部高等學(xué)校博士學(xué)科點(diǎn)專項(xiàng)科研基金(200800231051,20101106110046)。 * MERGEFORMAT國(guó)家自然科學(xué)基金(30800281,31170804);天津市自然科學(xué)基金重點(diǎn)項(xiàng)目(10JCZDJC16900,11ZCGYSY02400);教育部高等學(xué)校博士學(xué)科點(diǎn)專
15、項(xiàng)科研基金(200800231051,20101106110046)。SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET versi
16、on 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET version 1.5 * MERGEFORMAT1.5SET bkReferencesInfo 1*|*期刊*|*褚麗萍,劉強(qiáng),王芹等. mtDNA4977和彗星分析評(píng)價(jià)腫瘤細(xì)胞輻射敏感性研究J。中華放射醫(yī)學(xué)與防護(hù)雜志,2008,28(2):142-145。2*|*期刊*|*Chinnery PF, Samuels DC,Elson J, et al. Accumulation of mitochondrial
17、DNA mutations in ageing, cancer, and mitochondrial disease:is there a common mechanismJ? Lancet, 2002,360(9342):1323-1325.3*|*期刊*|*Kashkar H, Haefs C, Shin H, et al. XIAP-mediated caspase inhibition in Hodgkins lymphoma-derived B cellsJ. J Exp Med. 2003 Jul 21;198(2):341-347.4*|*期刊*|*DU C, Fang M, L
18、i Y, et a1. Smac,a mitochondrial protein that promotes cytochrome- dependent caspase activation by elimination IAP inhibitionJ. Ce11, 2000, l02(1):33-42.5*|*期刊*|*Verhagen AM, Ekert PG, Pakusch M, et a1. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagoniz
19、ing IAP proteinsJ. Cell, 2000, 102(1):43-53.6*|*期刊*|*Giagkousiklidis S, Vogler M, Westhoff M, et al. Sensitization for irradiation induced apoptosis by second mitochondria-derived activator of caspaseJ. Cancer Res. 2005, 65(22): 10502-10513.7*|*期刊*|*Srinivasula SM, Hegde R, Saleh A, et al. A conserv
20、ed XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosisJ. Nature. 2001, 410, 112-116.8*|*期刊*|*Liu Z, Sun C, Olejniczak ET,et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domainJ. Nature.2000, 408, 1004-1008.9*|*期刊*|*Srinivasula SM, Datta P,
21、 Fan XJ, et al. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathwayJ. J Biol Chem . 2000, 275, 36152-36157.10*|*期刊*|*Deveraux QL, Takahashi R, Salvesen GS, et a1. X-linked IAP is a direct inhibitor of cel1-death proteasesJ. Nature, 1997,
22、 388(6639): 300-304.11*|*期刊*|*Vucic D, Deshayes K, Ackerly H, et a1. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)J. J Biol Chem. 2002 , 277(14):12275-12279.12*|*期刊*|*Jia L, Patwari Y, Kelsey SM, et a1. Role of Smac in human leukaemic cell apoptosi
23、s and proliferationJ. Oncogene. 2003, 22(11):1589-1599.13*|*期刊*|*Chai J, Du C, Wu JW, et al. Structural and biochemical basis of apoptotic activation by Smac/DIABLOJ. Nature. 2000, 406, 855-862.14*|*期刊*|*Sohn D, Schulze-Osthoff K, Janicke RU. Caspase-8 can be activated by interchain proteolysis with
24、out receptor triggered dimerization during drug-induced apoptosisJ. J Biol Chem. 2005,8: 5267-5273.15*|*期刊*|*Guo F, Nimmanapalli R, hanthi Paranawithana S, et al. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO p
25、eptide potentiates epothilone B derivative(BMS 247550) and Apo-2L/TRAILinduced apoptosisJ. Blood, 2002, 99: 3419-3426.16*|*期刊*|*Yang L, Mashima T, Sato S, et al. Predominant Suppression of Apoptosome by Inhibitor of Apoptosis Protein in Non-Small Cell Lung Cancer H460 Cells: Therapeutic Effect of a
26、Novel Polyarginine-conjugated Smac PeptideJ. Cancer Res. 2003, 63: 831-837.17*|*期刊*|*Derossi D, Calvet S, Trembleau A, et al. Cell internalization of the third helix of the Antennapedia homeodomain is receptor- independentJ. J Biol Chem, 1996, 271(30):18188-1819318*|*期刊*|*Yang J, McEachern D, Li W,
27、et al. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspasesJ. Mol Cancer Ther. 2011 10(4):658-69.19*|*期刊*|*Schmidt N, Mishra A, Lai GH, et al. Arginine-rich cell-penetrating peptidesJ. FEBS Letters. 2010, 584:1806-1813.20*|*期
28、刊*|*Kamide K, Nakakubo H, Uno S, Fukamizu A. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modificationsJ. Int J Mol Med. 2010; 25(1): 41-51.21*|*期刊*|*Lim KS, Won YW, Park YS, Kim YH. Preparation and functional analysis of recombinant prote
29、in transduction domain-metallothionein fusion proteinsJ. Biochimie. 2010,92(8):964-70.22*|*期刊*|*Huerta S, Gao X, Livingston EH, et al. In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201J. Surgery. 2010 Aug;148(2):346-53.23*|*期刊*|*Cheung HH, Beug ST,
30、St Jean M, et al. Smac mimetic compounds potentiate interleukin-1 beta-mediated cell deathJ. J Biol Chem. 2010; 285(52):40612-23.24*|*期刊*|*Petersen SL, Peyton M, Minna JD, Wang X. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expressionJ. Proc Natl Acad Sci
31、 U S A. 2010; 107(26): 11936-41.25*|*期刊*|*Servida F, Lecis D, Scavullo C, et al. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis. Invest New DrugsJ
32、. 2011, 29(6):1264-75.26*|*期刊*|*Probst BL, Liu L, Ramesh V, et al. Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-dependent mannerJ. Cell Death Differ. 2010; 17(10):1645-54.27*|*期刊*|*Hosokawa Y, Sakakura Y, Tanaka L, Okumura K, Yajima T, Kaneko M. Radiation-induced apoptos
33、is is independent of caspase-8 but dependent on cytochrome c and the caspase-9 cascade in human leukemia HL60 cellsJ. J Radiat Res, 2005;46(3):293-303. * MERGEFORMAT1*|*期刊*|*褚麗萍,劉強(qiáng),王芹等. mtDNA4977和彗星分析評(píng)價(jià)腫瘤細(xì)胞輻射敏感性研究J。中華放射醫(yī)學(xué)與防護(hù)雜志,2008,28(2):142-145。2*|*期刊*|*Chinnery PF, Samuels DC,Elson J, et al. Accum
34、ulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease:is there a common mechanismJ? Lancet, 2002,360(9342):1323-1325.3*|*期刊*|*Kashkar H, Haefs C, Shin H, et al. XIAP-mediated caspase inhibition in Hodgkins lymphoma-derived B cellsJ. J Exp Med. 2003 Jul 21;198(2):341-347
35、.4*|*期刊*|*DU C, Fang M, Li Y, et a1. Smac,a mitochondrial protein that promotes cytochrome- dependent caspase activation by elimination IAP inhibitionJ. Ce11, 2000, l02(1):33-42.5*|*期刊*|*Verhagen AM, Ekert PG, Pakusch M, et a1. Identification of DIABLO, a mammalian protein that promotes apoptosis by
36、 binding to and antagonizing IAP proteinsJ. Cell, 2000, 102(1):43-53.6*|*期刊*|*Giagkousiklidis S, Vogler M, Westhoff M, et al. Sensitization for irradiation induced apoptosis by second mitochondria-derived activator of caspaseJ. Cancer Res. 2005, 65(22): 10502-10513.7*|*期刊*|*Srinivasula SM, Hegde R,
37、Saleh A, et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosisJ. Nature. 2001, 410, 112-116.8*|*期刊*|*Liu Z, Sun C, Olejniczak ET,et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domainJ. Nature.2000, 408, 1004-1008.9*|*期刊*|
38、*Srinivasula SM, Datta P, Fan XJ, et al. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathwayJ. J Biol Chem . 2000, 275, 36152-36157.10*|*期刊*|*Deveraux QL, Takahashi R, Salvesen GS, et a1. X-linked IAP is a direct inhibitor of cel1-death
39、proteasesJ. Nature, 1997, 388(6639): 300-304.11*|*期刊*|*Vucic D, Deshayes K, Ackerly H, et a1. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)J. J Biol Chem. 2002 , 277(14):12275-12279.12*|*期刊*|*Jia L, Patwari Y, Kelsey SM, et a1. Role of Smac in huma
40、n leukaemic cell apoptosis and proliferationJ. Oncogene. 2003, 22(11):1589-1599.13*|*期刊*|*Chai J, Du C, Wu JW, et al. Structural and biochemical basis of apoptotic activation by Smac/DIABLOJ. Nature. 2000, 406, 855-862.14*|*期刊*|*Sohn D, Schulze-Osthoff K, Janicke RU. Caspase-8 can be activated by in
41、terchain proteolysis without receptor triggered dimerization during drug-induced apoptosisJ. J Biol Chem. 2005,8: 5267-5273.15*|*期刊*|*Guo F, Nimmanapalli R, hanthi Paranawithana S, et al. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-
42、terminus of Smac/DIABLO peptide potentiates epothilone B derivative(BMS 247550) and Apo-2L/TRAILinduced apoptosisJ. Blood, 2002, 99: 3419-3426.16*|*期刊*|*Yang L, Mashima T, Sato S, et al. Predominant Suppression of Apoptosome by Inhibitor of Apoptosis Protein in Non-Small Cell Lung Cancer H460 Cells:
43、 Therapeutic Effect of a Novel Polyarginine-conjugated Smac PeptideJ. Cancer Res. 2003, 63: 831-837.17*|*期刊*|*Derossi D, Calvet S, Trembleau A, et al. Cell internalization of the third helix of the Antennapedia homeodomain is receptor- independentJ. J Biol Chem, 1996, 271(30):18188-1819318*|*期刊*|*Ya
44、ng J, McEachern D, Li W, et al. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspasesJ. Mol Cancer Ther. 2011 10(4):658-69.19*|*期刊*|*Schmidt N, Mishra A, Lai GH, et al. Arginine-rich cell-penetrating peptidesJ. FEBS Letters. 2
45、010, 584:1806-1813.20*|*期刊*|*Kamide K, Nakakubo H, Uno S, Fukamizu A. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modificationsJ. Int J Mol Med. 2010; 25(1): 41-51.21*|*期刊*|*Lim KS, Won YW, Park YS, Kim YH. Preparation and functional anal
46、ysis of recombinant protein transduction domain-metallothionein fusion proteinsJ. Biochimie. 2010,92(8):964-70.22*|*期刊*|*Huerta S, Gao X, Livingston EH, et al. In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201J. Surgery. 2010 Aug;148(2):346-53.23*|*
47、期刊*|*Cheung HH, Beug ST, St Jean M, et al. Smac mimetic compounds potentiate interleukin-1 beta-mediated cell deathJ. J Biol Chem. 2010; 285(52):40612-23.24*|*期刊*|*Petersen SL, Peyton M, Minna JD, Wang X. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expres
48、sionJ. Proc Natl Acad Sci U S A. 2010; 107(26): 11936-41.25*|*期刊*|*Servida F, Lecis D, Scavullo C, et al. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apo
49、ptosis. Invest New DrugsJ. 2011, 29(6):1264-75.26*|*期刊*|*Probst BL, Liu L, Ramesh V, et al. Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-dependent mannerJ. Cell Death Differ. 2010; 17(10):1645-54.27*|*期刊*|*Hosokawa Y, Sakakura Y, Tanaka L, Okumura K, Yajima T, Kaneko M.
50、Radiation-induced apoptosis is independent of caspase-8 but dependent on cytochrome c and the caspase-9 cascade in human leukemia HL60 cellsJ. J Radiat Res, 2005;46(3):293-303.SET bkAuthorsInfo |1|劉強(qiáng)|Liu Qiang|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;天津市分子核醫(yī)學(xué)重點(diǎn)實(shí)驗(yàn)室,天津 300192|Institute of Radiation Medicine, Chinese Academy of
51、 Medical Science & Peking Union Medical College, Tianjin 300192|劉強(qiáng)(1974-),男,研究員,主要從事放射生物學(xué)研究|天津市南開(kāi)區(qū)白堤路238號(hào)|300192|dr.qiangliu13612072983|2|杜利清|Du Liqing|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|3|曹嘉
52、|Cao Jia|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|jillpumc|4|王彥|Wang Yan|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|bamboo19
53、750930|5|王宏|Wang Hong|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|biotechong|6|陳鳳華|Chen Fenghua|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tia
54、njin 300192|7|付岳|Fu Yue|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|wddr0710|8|郭艷婷|Guo Yanting|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tian
55、jin 300192|*|9|樊飛躍|Fan Feiyue|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|樊飛躍(1958-),男,研究員,主要從事放射生物學(xué)研究|天津市南開(kāi)區(qū)白堤路238號(hào)|300192|faithyfan13672122168 * MERGEFORMAT|1|劉強(qiáng)|Liu Qiang|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所;天津市分子核醫(yī)學(xué)重點(diǎn)實(shí)
56、驗(yàn)室,天津 300192|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|劉強(qiáng)(1974-),男,研究員,主要從事放射生物學(xué)研究|天津市南開(kāi)區(qū)白堤路238號(hào)|300192|dr.qiangliu13612072983|2|杜利清|Du Liqing|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Med
57、ical Science & Peking Union Medical College, Tianjin 300192|3|曹嘉|Cao Jia|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|jillpumc|4|王彥|Wang Yan|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical
58、 Science & Peking Union Medical College, Tianjin 300192|bamboo19750930|5|王宏|Wang Hong|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|biotechong|6|陳鳳華|Chen Fenghua|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chines
59、e Academy of Medical Science & Peking Union Medical College, Tianjin 300192|7|付岳|Fu Yue|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|wddr0710|8|郭艷婷|Guo Yanting|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|*|9|樊飛躍|Fan Feiyue|中國(guó)醫(yī)學(xué)科學(xué)院放射醫(yī)學(xué)研究所|Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192|樊飛躍(1958-),男,研究員,主要從事放射生物學(xué)研究|天津市南開(kāi)區(qū)白堤路238號(hào)|300192|faithyfan|022-85
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 專業(yè)工業(yè)廠房買(mǎi)賣合同范本
- 合同范本彩鋼棚
- 公家車庫(kù)出租合同范本
- 發(fā)廊股東協(xié)議合同范本
- 北京中開(kāi)合同范本
- 合建房合同范本
- 勞動(dòng)合同范本企業(yè)
- 從化醫(yī)院食堂承包合同范本
- 項(xiàng)目合作定金合同范本
- 合同范本范本
- 2025中智集團(tuán)招聘高頻重點(diǎn)提升(共500題)附帶答案詳解
- 新疆所有煤礦基本信息
- DB33T 2515-2022 公共機(jī)構(gòu)“零碳”管理與評(píng)價(jià)規(guī)范
- 通站(2017)8012 鐵路站場(chǎng)排水構(gòu)筑物
- 2024-2025學(xué)年上學(xué)期上海初中英語(yǔ)七年級(jí)期末模擬試卷2
- 2024-2025學(xué)年上學(xué)期河北初中英語(yǔ)八年級(jí)期末試卷
- 極端天氣下的新能源電力系統(tǒng)電力電量平衡體系
- 成人重癥患者人工氣道濕化護(hù)理專家共識(shí)解讀教學(xué)課件
- 教育技術(shù)學(xué)導(dǎo)論 黃榮懷(第2版)學(xué)習(xí)通超星期末考試答案章節(jié)答案2024年
- 英語(yǔ)課件音標(biāo)教學(xué)課件
- 2024年湖北省中考語(yǔ)文真題(學(xué)生版+解析版)
評(píng)論
0/150
提交評(píng)論